J&J Takes Innovative, If Pricey, Route To Ending Hip Suits

By Greg Ryan (November 21, 2013, 8:31 PM EST) -- In Tuesday's hip implant deal, Johnson & Johnson took the unusual step of accepting responsibility for most of the plaintiffs' insurance liens for surgery costs, a promise that jacks up — perhaps substantially— its $2.5 billion tab, but removes an obstacle to resolution that has increasingly stymied defendants in mass tort litigation....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!